OR WAIT null SECS
May 11, 2016
AMRI’s acquisition of Euticals expands its API development and manufacturing business.
May 04, 2016
The production of antibody-drug conjugates requires biopharmaceutical and chemical manufacturing, and conjugation capabilities.
May 02, 2016
Safe handling of HPAPIs requires determining exposure potential and selecting appro-priate containment strategies.
Bioprocess operations-from cell line selection to final filtration-can influence the consistency and purity of biologic drug substances.
April 18, 2016
Shire announces plans to build a flexible biopharmaceutical manufacturing facility in County Meath, Ireland.
April 02, 2016
Manufacturing highly toxic compounds in a biopharmaceutical environment tests equipment and systems.
A global API marketplace increases the burden of supply chain monitoring for drug companies.
April 01, 2016
Unsafe material may remain in the US supply chain, according to a March 29th letter to FDA Commissioner Califf
March 29, 2016
Novo Nordisk broke ground on a facility in Clayton, NC, to manufacture APIs for GLP-1 and insulin medicines.
March 24, 2016
Collaboration will provide for unified development and manufacture of antibody drug conjugates.